Friday, February 26, 2021
Home Life Style Health & Fitness Prostate Drug May Lower Parkinson's Disease Risk In Men

Prostate Drug May Lower Parkinson’s Disease Risk In Men

The studies found that a longer duration of use of the energy-enhancing prostate drugs was associated with increased protective effects

Taking a particular type of medication to treat an enlarged prostate is associated with a reduced risk of developing Parkinson’s disease among men, a new study suggests. The findings, published in the journal JAMA Neurology, provide compelling evidence that terazosin, and similar medications, might have the potential to prevent or delay the development of Parkinson’s disease.

“Men taking terazosin were 12 percent to 37 percent less likely to develop Parkinson’s disease during follow-up than men taking tamsulosin,” said Jacob Simmering, Assistant Professor at the University of Iowa in the US. The findings build on previous preclinical research by the team, which showed that terazosin enhances cellular energy levels and can prevent or slow the progression of Parkinson’s disease in animal models.

Follow NewsGram on Twitter to stay updated about the World news.

In this earlier study, the team also used the Truven database to show that men with Parkinson’s disease who were also taking terazosin and the related prostate drug had reduced signs, symptoms, and complications of Parkinson’s disease.

ALSO READ: Study: Keeping Plants At Home Can Keep You Mentally Healthy

Tamsulosin is another prostate drug commonly used to treat an enlarged prostate, but unlike terazosin, tamsulosin has no effect on cellular energy production, which the team’s lab studies suggest is important in terazosin’s protective effect. The new study extends these findings to investigate whether terazosin and related drugs that can also enhance cellular energy production are associated with a reduced risk of developing Parkinson’s disease.

For the study, the team identified 150,000 men newly started on terazosin or similar medications and matched them, based on age and clinical history to 150,000 men newly started on tamsulosin. Additionally, the study found that a longer duration of use of the energy-enhancing prostate drugs was associated with increased protective effects. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Cyberattacks Per Healthcare Organization Jumped 37 Percent In The Last 12 Months

Cyberattacks on hospitals and healthcare organizations have emerged as a top hacker trend in 2020, as monthly cyberattacks per healthcare organization jumped 37 percent...

Zoom App To Launch Automatic Closed Captioning Feature

Video conferencing app Zoom said it is working towards making "automatic closed captioning" available for all the free account holders to make the service...

B-Town Producers Don’t Have Investment, Talent as OTT Platforms Have: Abhay Deol

Bollywood producers neither have the money nor talent to cater to audiences who want something beyond the popular and the mainstream, claims actor Abhay...

How Delhi Police Reunited a Divyang Person With His Family Based on Just One Word “Hospital”

The Delhi Police reunited a 30-year-old divyang person with his family following a lead based on just one word - Hospital. On the intervening night...

COVID Lockdown Lead To Increase in The Cases of Domestic Violence: Study

While Covid-19 related lockdowns may have decreased the spread of a deadly virus, they appear to have created an environment for increased domestic violence,...

Number Of Digitally Skilled Workers To Grow 9X In India By 2025

The number of workers in India requiring digital skills will need to increase nine times by 2025, and the average worker will need to...

The Union Government Releases New Guidelines For Social Media, OTT

The Union Government on Thursday came up with new stringent guidelines for social media platforms along with a code of ethics for over-the-top (OTT)...

Businesses In India To Implement Robotic Process Automation By 2024

Nearly half of all businesses in India will implement robotic process automation (RPA) by 2024, said an IDC study on Wednesday. The study commissioned...

Recent Comments